Kyoto, Japan

Masahiro Amakawa



 

Average Co-Inventor Count = 5.1

ph-index = 3

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 2000-2015

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Masahiro Amakawa: Innovator in Pharmaceutical Compounds

Introduction

Masahiro Amakawa is a prominent inventor based in Kyoto, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target various diseases. With a total of 6 patents to his name, Amakawa's work has the potential to impact numerous medical conditions.

Latest Patents

One of Amakawa's latest patents involves an EP4 agonist. This compound is represented by a specific formula, where R and R' can independently be a hydrogen atom or a straight chain alkyl group with a carbon number of 1-3. The compound exhibits selective EP4 agonist action, which is distinct from known PGI analogs. It is designed for use in medicaments that can help in the prophylaxis and treatment of a wide range of diseases, including immune diseases, cardiovascular diseases, and neurological disorders.

Career Highlights

Throughout his career, Masahiro Amakawa has worked with notable companies such as Kaken Pharmaceutical Company, Ltd. and Asahi Glass Company, Limited. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.

Collaborations

Amakawa has collaborated with several professionals in his field, including Takahiko Murata and Shin Teradaira. These partnerships have likely enhanced his research and development efforts.

Conclusion

Masahiro Amakawa's contributions to pharmaceutical innovations, particularly through his patents, demonstrate his commitment to advancing medical science. His work continues to hold promise for the treatment of various diseases, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…